JERUSALEM, Israel, November 30 /PRNewswire-FirstCall/ -- IDenta Corp. today released a summary of meetings completed during a special November visit to Washington, D.C. and south Florida by CEO, Yaccov Shoham. The statement provided insight into the legal areas IDenta has identified as critical for successfully competing for U.S. government contracts. Identa also announced that it has entered into an affiliate agreement with Orange Blossom Ventures Ltd., (OBV), to develop business opportunities for Identa’s products both in the states and internationally.
“Identa’s legal strategy can be summed up in two words - undisputable truth,” Shoham asserted. “In Washington D.C. we had four high level meetings with lobbyists and legal consultants to share with them the approvals our products have received from such bodies as the Commonwealth of Virginia. We now need to achieve the same success at the Federal and Capital levels of government, and smoothly integrate our presentations and documentation into this very complicated but profitable marketplace.” Specific proposals from the lobbying groups are now being received and reviewed.
In a second type of legal meeting, Shoham met with an unnamed but very prominent “U.S. Criminal Attorney” to strategize tackling the issue of making drug detection products admissible in the courts. From information gathered in that meeting, Identa now believes that cases already ruled on by the US Supreme Court may have the precedence needed for results of their drug tests to be entered as evidence. IDenta is now co-authoring product testing validation that could make the admission much easier.
ABOUT OBV
Orange Blossom Ventures (OBV), www.obv.co.il, with offices in Tel Aviv, Israel and Miami, Fla., provides professional and business development services to internationally expanding businesses based in Israel and to overseas businesses desiring to expand into Israel.
ABOUT IDENTA
Identa Corporation is a leader in the development of proprietary on-site drug detection kits used by governments and security forces around the world. Information concerning Identa’s business plan and product line, including rapid test kits (substance only) for the detection of marijuana, hashish, ecstasy, cocaine, crack, heroin and methamphetamines may be found at www.identa.biz and www.drugsdetector.com.
Identa supports “D.A.M.M.A.D.D.,” Dads and Mad Moms Against Drug Dealers, (www.dammadd.org)
For Investor Relations, lobbying interests or information concerning IDenta’s products internationally contact:
Yaacov Shoham, Identa Corp., CEO Tel: +972-52-6554487, +972-8-9716874 Fax: +972-8-9716875 fpi@drugsdetector.com
Certain of the statements contained herein may be, within the meaning of the federal securities laws, “forward-looking statements” that are subject to risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These forward-looking statements are based on management’s expectations as of the date hereof, and the company does not undertake any responsibility to update any of these statements in the future.
Identa Corp
CONTACT: Yaacov Shoham, Identa Corp., CEO, Tel: +972-52-6554487,+972-8-9716874, Fax: +972-8-9716875, fpi@drugsdetector.com